Zura Bio (ZURA) Competitors $1.31 -0.08 (-5.76%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$1.34 +0.02 (+1.91%) As of 07/11/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZURA vs. GOSS, ALT, GLUE, RNAC, TKNO, RCKT, FHTX, ADCT, AVTE, and TSVTShould you be buying Zura Bio stock or one of its competitors? The main competitors of Zura Bio include Gossamer Bio (GOSS), Altimmune (ALT), Monte Rosa Therapeutics (GLUE), Cartesian Therapeutics (RNAC), Alpha Teknova (TKNO), Rocket Pharmaceuticals (RCKT), Foghorn Therapeutics (FHTX), ADC Therapeutics (ADCT), Aerovate Therapeutics (AVTE), and 2seventy bio (TSVT). These companies are all part of the "pharmaceutical products" industry. Zura Bio vs. Its Competitors Gossamer Bio Altimmune Monte Rosa Therapeutics Cartesian Therapeutics Alpha Teknova Rocket Pharmaceuticals Foghorn Therapeutics ADC Therapeutics Aerovate Therapeutics 2seventy bio Gossamer Bio (NASDAQ:GOSS) and Zura Bio (NASDAQ:ZURA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership. Do insiders & institutionals believe in GOSS or ZURA? 81.2% of Gossamer Bio shares are held by institutional investors. Comparatively, 61.1% of Zura Bio shares are held by institutional investors. 6.7% of Gossamer Bio shares are held by company insiders. Comparatively, 22.1% of Zura Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is GOSS or ZURA more profitable? Zura Bio has a net margin of 0.00% compared to Gossamer Bio's net margin of -41.12%. Zura Bio's return on equity of -42.84% beat Gossamer Bio's return on equity.Company Net Margins Return on Equity Return on Assets Gossamer Bio-41.12% -128.98% -15.52% Zura Bio N/A -42.84%-35.22% Which has better valuation and earnings, GOSS or ZURA? Zura Bio has lower revenue, but higher earnings than Gossamer Bio. Gossamer Bio is trading at a lower price-to-earnings ratio than Zura Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGossamer Bio$114.70M2.70-$56.53M-$0.23-5.91Zura BioN/AN/A-$45.39M-$0.70-1.87 Which has more risk & volatility, GOSS or ZURA? Gossamer Bio has a beta of 1.86, indicating that its share price is 86% more volatile than the S&P 500. Comparatively, Zura Bio has a beta of -0.1, indicating that its share price is 110% less volatile than the S&P 500. Does the media refer more to GOSS or ZURA? In the previous week, Zura Bio had 4 more articles in the media than Gossamer Bio. MarketBeat recorded 5 mentions for Zura Bio and 1 mentions for Gossamer Bio. Gossamer Bio's average media sentiment score of 1.89 beat Zura Bio's score of 0.50 indicating that Gossamer Bio is being referred to more favorably in the media. Company Overall Sentiment Gossamer Bio Very Positive Zura Bio Positive Do analysts prefer GOSS or ZURA? Gossamer Bio currently has a consensus price target of $7.33, indicating a potential upside of 439.22%. Zura Bio has a consensus price target of $14.33, indicating a potential upside of 994.15%. Given Zura Bio's stronger consensus rating and higher probable upside, analysts clearly believe Zura Bio is more favorable than Gossamer Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Gossamer Bio 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Zura Bio 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 SummaryZura Bio beats Gossamer Bio on 10 of the 16 factors compared between the two stocks. Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZURA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZURA vs. The Competition Export to ExcelMetricZura BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$89.57M$2.94B$5.55B$9.09BDividend YieldN/A2.45%5.07%4.03%P/E Ratio-1.8720.8528.2520.31Price / SalesN/A295.87433.2199.68Price / CashN/A41.0526.2427.98Price / Book0.587.638.125.50Net Income-$45.39M-$55.05M$3.19B$250.38M7 Day Performance15.32%8.43%3.62%4.79%1 Month Performance9.17%8.14%5.98%9.59%1 Year Performance-64.69%1.62%29.39%16.41% Zura Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZURAZura Bio2.8742 of 5 stars$1.31-5.8%$14.33+994.1%-64.7%$89.57MN/A-1.873News CoveragePositive NewsGap UpGOSSGossamer Bio3.8176 of 5 stars$1.23-1.6%$7.33+496.2%+16.2%$284.13M$114.70M-5.35180ALTAltimmune2.2272 of 5 stars$3.87+10.6%$19.00+391.0%-47.6%$283.87M$20K-3.0750News CoverageAnalyst ForecastHigh Trading VolumeGLUEMonte Rosa Therapeutics2.038 of 5 stars$4.51-2.0%$15.33+240.0%+19.4%$282.95M$75.62M56.3890RNACCartesian Therapeutics2.2469 of 5 stars$10.39-2.7%$41.25+297.0%-24.9%$277.19M$38.91M-0.2064News CoverageAnalyst ForecastAnalyst RevisionGap DownTKNOAlpha Teknova2.2392 of 5 stars$4.91-3.9%$8.50+73.1%+275.8%$273.08M$37.74M-10.23240Positive NewsRCKTRocket Pharmaceuticals4.8613 of 5 stars$2.45-3.2%$18.60+659.2%-86.8%$270.17MN/A-0.93240Trending NewsFHTXFoghorn Therapeutics1.9563 of 5 stars$4.70-2.9%$12.13+158.0%-12.5%$269.79M$22.60M-3.46120Positive NewsGap DownADCTADC Therapeutics1.5261 of 5 stars$2.69-0.7%$7.75+188.1%-17.3%$268.77M$70.84M-1.86310News CoverageAVTEAerovate TherapeuticsN/A$9.19-0.6%N/A-84.5%$266.37MN/A-3.0720High Trading VolumeTSVT2seventy bioN/A$5.00flat$5.00N/A$266.15M$48.37M-2.69440 Related Companies and Tools Related Companies GOSS Alternatives ALT Alternatives GLUE Alternatives RNAC Alternatives TKNO Alternatives RCKT Alternatives FHTX Alternatives ADCT Alternatives AVTE Alternatives TSVT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZURA) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zura Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
